Tie Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 25-12-2024
- Paid Up Capital ₹ 0.15 M
as on 25-12-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2018
- Revenue -22.94%
(FY 2018)
- Profit -82.43%
(FY 2018)
- Ebitda -80.89%
(FY 2018)
- Net Worth 43.92%
(FY 2018)
- Total Assets -26.28%
(FY 2018)
About Tie Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Mishra, Smita Dubey, and Krishnadatta Dubey serve as directors at the Company.
- CIN/LLPIN
U85191MH2013PTC243686
- Company No.
243686
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2013
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Tie Life Science Private Limited offer?
Tie Life Science Private Limited offers a wide range of products and services, including Herbal Capsules, Pantoprazole Drugs, Pantoprazole Sodium Injection, Nutraceuticals & Dietary Supplements, Fitness Supplements, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Common Disease Medicines, Pharmaceutical Syrup, Pain Reliever Gel.
Who are the key members and board of directors at Tie Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Smita Dubey  | Managing Director | 27-May-2013 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Mishra | Director | 27-May-2013 | Current |
| Krishnadatta Dubey | Director | 27-May-2013 | Current |
Financial Performance of Tie Life Science.
Tie Life Science Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 22.94% decrease. The company also saw a substantial fall in profitability, with a 82.43% decrease in profit. The company's net worth Soared by an impressive increase of 43.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tie Life Science?
In 2018, Tie Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tie Life Science?
Unlock and access historical data on people associated with Tie Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tie Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tie Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
